IDYA
Price
$31.81
Change
-$0.14 (-0.44%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
2.8B
138 days until earnings call
Intraday BUY SELL Signals
PCVX
Price
$45.56
Change
-$0.54 (-1.17%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
6.04B
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IDYA vs PCVX

Header iconIDYA vs PCVX Comparison
Open Charts IDYA vs PCVXBanner chart's image
IDEAYA Biosciences
Price$31.81
Change-$0.14 (-0.44%)
Volume$10.63K
Capitalization2.8B
Vaxcyte
Price$45.56
Change-$0.54 (-1.17%)
Volume$27.42K
Capitalization6.04B
IDYA vs PCVX Comparison Chart in %
IDYA
Daily Signal:
Gain/Loss:
PCVX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IDYA vs. PCVX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a StrongBuy and PCVX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (IDYA: $31.95 vs. PCVX: $46.10)
Brand notoriety: IDYA and PCVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 69% vs. PCVX: 65%
Market capitalization -- IDYA: $2.8B vs. PCVX: $6.04B
IDYA [@Biotechnology] is valued at $2.8B. PCVX’s [@Biotechnology] market capitalization is $6.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $110.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 1 FA rating(s) are green whilePCVX’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 1 green, 4 red.
  • PCVX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IDYA and PCVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 3 TA indicator(s) are bullish while PCVX’s TA Score has 3 bullish TA indicator(s).

  • IDYA’s TA Score: 3 bullish, 5 bearish.
  • PCVX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а +7.72% price change this week, while PCVX (@Biotechnology) price change was +14.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

IDYA is expected to report earnings on Mar 31, 2026.

PCVX is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($6.04B) has a higher market cap than IDYA($2.8B). IDYA YTD gains are higher at: 24.319 vs. PCVX (-43.684). IDYA has higher annual earnings (EBITDA): -380.2M vs. PCVX (-584.35M). PCVX has more cash in the bank: 1.66B vs. IDYA (670M). IDYA has less debt than PCVX: IDYA (26.6M) vs PCVX (85.8M). IDYA has higher revenues than PCVX: IDYA (7M) vs PCVX (0).
IDYAPCVXIDYA / PCVX
Capitalization2.8B6.04B46%
EBITDA-380.2M-584.35M65%
Gain YTD24.319-43.684-56%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash670M1.66B40%
Total Debt26.6M85.8M31%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
63
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAPCVX
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 9 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signal:
Gain/Loss:
PCVX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CEUCX63.140.47
+0.75%
American Funds EUPAC 529-C
IHOIX23.180.12
+0.52%
Hartford International Opportunities I
JHJCX23.920.06
+0.25%
JHancock ESG Large Cap Core C
CMCRX45.150.10
+0.22%
Calvert US Mid Cap Core Rspnb Idx R6
AVUVX17.940.03
+0.17%
Avantis® U.S. Small Cap Value Instl

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with NUVL. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-0.19%
NUVL - IDYA
59%
Loosely correlated
+0.91%
NRIX - IDYA
58%
Loosely correlated
-5.37%
IMNM - IDYA
57%
Loosely correlated
-0.51%
CGON - IDYA
57%
Loosely correlated
+1.47%
XENE - IDYA
57%
Loosely correlated
-0.60%
More

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with NUVL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
+0.96%
NUVL - PCVX
47%
Loosely correlated
+0.91%
IDYA - PCVX
47%
Loosely correlated
-0.19%
KYMR - PCVX
47%
Loosely correlated
+0.25%
TSHA - PCVX
45%
Loosely correlated
+1.87%
BEAM - PCVX
45%
Loosely correlated
-2.71%
More